<SEC-DOCUMENT>0001193125-14-437844.txt : 20141209
<SEC-HEADER>0001193125-14-437844.hdr.sgml : 20141209
<ACCEPTANCE-DATETIME>20141209172300
ACCESSION NUMBER:		0001193125-14-437844
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20141209
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20141209
DATE AS OF CHANGE:		20141209

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CONMED CORP
		CENTRAL INDEX KEY:			0000816956
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				160977505
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-16093
		FILM NUMBER:		141275882

	BUSINESS ADDRESS:	
		STREET 1:		525 FRENCH ROAD
		CITY:			UTICA
		STATE:			NY
		ZIP:			13502
		BUSINESS PHONE:		315-624-3215

	MAIL ADDRESS:	
		STREET 1:		525 FRENCH ROAD
		CITY:			UTICA
		STATE:			NY
		ZIP:			13502
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d834990d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): December&nbsp;9, 2014 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>CONMED CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>New York</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>0-16093</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>16-0977505</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other Jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of Incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>525 French Road</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Utica, New York</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>13502</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>(Address of Principal Executive Offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: (315)&nbsp;797-8375 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or former address if changed since last report.) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b)(c)(e) </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;9, 2014, CONMED Corporation (the &#147;Company&#148;) announced that Robert D. Shallish, Jr. is retiring from his position as
the Company&#146;s Executive Vice President, Finance and Chief Financial Officer, effective as of March&nbsp;31, 2015. The Board of Directors of the Company (the &#147;Board&#148;) has appointed Luke Pomilio, who is currently the Company&#146;s
Executive Vice President, Controller and Corporate General Manager, as Executive Vice President, Finance and Chief Financial Officer of the Company to succeed Mr.&nbsp;Shallish, effective as of April&nbsp;1, 2015. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with Mr.&nbsp;Shallish&#146;s retirement, the Company entered into a letter agreement with Mr.&nbsp;Shallish, dated
December&nbsp;9, 2014 (the &#147;Retirement Agreement&#148;). Pursuant to the Retirement Agreement, Mr.&nbsp;Shallish will be eligible to receive, subject to his continuous employment with the Company through March&nbsp;31, 2015: (i)&nbsp;payment of
the retention bonus pursuant to his letter agreement with the Company dated July&nbsp;23, 2014; (ii)&nbsp;payment of the 20% &#147;holdback&#148; from the 2013 Bonus Plan at the time when other similarly situated executives receive such holdback
payments, provided that 2014 adjusted EPS is not less than $1.66 and (iii)&nbsp;payment of any amount Mr.&nbsp;Shallish may earn for 2014 under the terms of the Company&#146;s 2014 Executive Bonus Plan, payable at the time when other similarly
situated executives receive such payments. Mr.&nbsp;Shallish&#146;s retirement will be deemed to be with the consent of the Compensation Committee of the Board, and in accordance with their terms, any outstanding, unvested equity awards held by him
as of March&nbsp;31, 2015 shall vest, and any issued stock appreciation rights shall vest and will remain exercisable for one (1)&nbsp;year. The above description is qualified in its entirety by reference to the terms of the Retirement Agreement
with Mr.&nbsp;Shallish, which is attached hereto as Exhibit 10.1 and incorporated herein by reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Pomilio (age 50) joined
the Company as Controller in September 1995. Subsequently, Mr.&nbsp;Pomilio assumed additional responsibility for certain corporate functions, including worldwide operations and select administrative functions. In May 2009, Mr.&nbsp;Pomilio was
promoted to Vice President, Controller and Corporate General Manager. In March 2013, Mr.&nbsp;Pomilio&#146;s title was changed to Executive Vice President, Controller and Corporate General Manager. Mr.&nbsp;Pomilio is a certified public accountant
and graduated with a B.S. degree in Accounting from Clarkson University. There are no related-party transactions that would be required to be disclosed under Item&nbsp;404(a) of Regulation S-K with respect to Mr.&nbsp;Pomilio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, effective as of December&nbsp;31, 2014, Joseph Darling&#146;s position as the Company&#146;s Executive Vice President, Commercial
Operations is being eliminated, and his employment as an officer and employee of the Company and its subsidiaries will terminate on that date. In connection with his employment termination, the Company entered into a separation and release agreement
with Mr.&nbsp;Darling, dated December&nbsp;9, 2014 (the &#147;Separation Agreement&#148;), with respect to the terms of his separation. The Separation Agreement supersedes Mr.&nbsp;Darling&#146;s Executive Severance Agreement with CONMED dated
May&nbsp;1, 2008 and his Change in Control Severance Agreement with the Company dated May&nbsp;3, 2010. Pursuant to the Separation Agreement, Mr.&nbsp;Darling will be eligible to receive: (i)&nbsp;an amount equal to his current base annual salary
($385,770), payable in a lump sum within ten days after December&nbsp;31, 2014; (ii)&nbsp;beginning in January 2016, an amount equal to one-half his current base salary ($192,885), payable in six equal monthly installments, provided that any right
to such receive such installments will cease if and when Mr.&nbsp;Darling obtains new employment or engagement as a consultant; (iii)&nbsp;pursuant to the terms of the Company&#146;s 2014 Executive Bonus Plan, payment of the 20% &#147;holdback&#148;
from the 2013 Bonus Plan at the time when other similarly situated executives receive such holdback payments, provided that 2014 adjusted EPS is not less than $1.66; (iv)&nbsp;payment of any amount Mr.&nbsp;Darling may earn for 2014 under the terms
of the Company&#146;s 2014 Executive Bonus Plan, payable at the time when other similarly situated executives receive such payments and (v)&nbsp;reduced COBRA premiums for up to 18 months. Mr.&nbsp;Darling will remain subject to the
non-disparagement and confidentiality restrictions pursuant to his confidentiality agreement with the Company, and the Company has waived certain post-employment restrictions that would have been applicable to Mr.&nbsp;Darling. Treatment of
outstanding equity awards previously granted to Mr.&nbsp;Darling for his prior service will be determined by the terms of such equity award agreements. The above description is qualified in its entirety by reference to the terms of the Separation
Agreement with Mr.&nbsp;Darling, which is attached hereto as Exhibit 10.2 and incorporated herein by reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A copy of the press
release announcing the events described above is attached as Exhibit 99.1 and is incorporated herein by reference. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;7.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Regulation FD Disclosure. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;9, 2014, the Company announced that Patrick
Beyer, former CEO of ICNet and former head of Stryker Europe, has been appointed President of CONMED International, effective immediately. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"><U>Exhibits</U> </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:39.10pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit&nbsp;No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:75.45pt; font-size:8pt; font-family:Times New Roman"><B>Description of Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Retirement Agreement, by and between CONMED Corporation and Robert Shallish, Jr., dated December&nbsp;9, 2014.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Separation Agreement, by and between CONMED Corporation and Joseph Darling, dated December&nbsp;9, 2014.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release, dated December&nbsp;9, 2014, issued by CONMED Corporation.</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CONMED CORPORATION</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">(Registrant)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Daniel S. Jonas</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Daniel S. Jonas, Esq.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Executive Vice President &#150; Legal Affairs &amp; General Counsel</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: December&nbsp;9, 2014 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:39.10pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit&nbsp;No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:75.45pt; font-size:8pt; font-family:Times New Roman"><B>Description of Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Retirement Agreement, by and between CONMED Corporation and Robert Shallish, Jr., dated December&nbsp;9, 2014.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Separation Agreement, by and between CONMED Corporation and Joseph Darling, dated December&nbsp;9, 2014.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release, dated December&nbsp;9, 2014, issued by CONMED Corporation.</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d834990dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g834990img003.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;9,&nbsp;2014</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Robert&nbsp;D. Shallish, Jr.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4375 Olympus Heights</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Syracuse, New York 13215</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Retirement </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Rob: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This letter sets forth the understanding between you and CONMED Corporation regarding your retirement on March&nbsp;31, 2015 (your
&#147;Retirement Date&#148;). </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">The Company waives your commitment to stay through June&nbsp;30, 2015 as contemplated by the letter agreement dated July&nbsp;23, 2014 and agrees to pay you a lump sum of $333,086.96, subject to normal withholdings,
within ten (10)&nbsp;days of your Retirement Date; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">The Compensation Committee of the Board of Directors, and the Board of Directors, have agreed that any outstanding, unvested equity awards held by you as of your Retirement Date shall accelerate and remain exercisable
for one (1)&nbsp;year. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top">The Company will also pay you any amount that you may earn for the year-ended December&nbsp;31, 2014 under the terms of the 2014 Executive Bonus Plan at the time when other similarly situated executives receive such
payments but in no event later than March&nbsp;15, 2015. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top">Pursuant to the terms of the 2014 Executive Bonus Plan, the Company will pay you the 20% &#147;holdback&#148; from the 2013 Bonus Plan at the time when other similarly situated executives receive such holdback payments
but in no event later than March&nbsp;15, 2015, <U>provided</U> that 2014 adjusted EPS is not less than $1.66. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please let
me know if you have any questions or concerns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Very truly yours, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">C<SMALL>ONMED</SMALL> C<SMALL>ORPORATION</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">/s/ Heather L. Cohen </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Heather L. Cohen </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Executive Vice President &#150; HR </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">cc:</TD>
<TD ALIGN="left" VALIGN="top">Curt Hartman, President&nbsp;&amp; CEO </TD></TR></TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Dirk Kuyper, Chairman of Compensation Committee </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Daniel S. Jonas, Esq, EVP&nbsp;&amp; General Counsel </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>d834990dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g834990img003.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top">December&nbsp;9, 2014</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Joseph Darling</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">501 Mandalay Avenue</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unit 409</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Clearwater Beach, Florida 33767</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"><U>Separation and Release Agreement</U> </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Joe: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This letter agreement (&#147;<U>Letter Agreement</U>&#148;) sets forth the understanding between you and CONMED Corporation (together with its
subsidiaries, affiliates, and other related entities, the &#147;<U>Company</U>&#148;) regarding your separation from the Company. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Termination of Employment Agreement </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your employment with the Company will terminate on
December&nbsp;31, 2014 (the &#147;<U>Termination Date</U>&#148;). It is agreed that you hereby resign, as of the Termination Date, from any and all offices, board memberships and other positions you hold with the Company. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Separation Payments </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon your termination of employment, you will be entitled to the
following payments and benefits (in each case, less applicable withholdings): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">The Company will pay you, within ten (10)&nbsp;days after the Termination Date, a lump sum of $385,770, which is equal to your current base annual salary; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">The Company will pay you, beginning in January 2016, the sum of $192,885, which is equal to one half of your current base annual salary, payable in six (6)&nbsp;equal monthly installments, provided that, beginning
January 2016, you provide the Company a monthly certification in a form reasonably satisfactory to the Company, signed by you attesting that you remain unemployed, and not acting as a consultant or agent earning income (other than income as provided
herein) since the Termination Date. In the event that you become employed or otherwise do not provide such certification in a timely manner, payments under this Paragraph 2(b) shall cease. A form of certification satisfactory to the Company is
attached hereto as Exhibit A. </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joseph Darling </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Separation and Release Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">December 9, 2014 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 of 8 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top">Pursuant to the terms of the 2014 Executive Bonus Plan, the Company will pay you the 20% &#147;holdback&#148; from the 2013 Bonus Plan at the time when other similarly situated executives receive such holdback payments
but in no event later than March&nbsp;15, 2015, <U>provided</U> that 2014 adjusted EPS is not less than $1.66; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top">The Company will also pay you any amount that you may earn for the year-ended December&nbsp;31, 2014 under the terms of the 2014 Executive Bonus Plan at the time when other similarly situated executives receive such
payments but in no event later than March&nbsp;15, 2015; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top">You will be eligible for a reduced COBRA rate for the medical and/or dental coverage which you may elect to continue through June 2016 or such other later time as allowed by law. Thereafter, the regular COBRA rate will
be due for the remainder of the COBRA period. The reduced COBRA rate is the monthly equivalent of the employee contribution rate for the plans that you elect; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top">The Company will pay you within 10 (ten) days after the Termination Date, (i)&nbsp;any earned but unpaid annual base salary, (ii)&nbsp;any unreimbursed business expenses, in accordance with the Company&#146;s applicable
expense reimbursement policies and (iii)&nbsp;one (1)&nbsp;week of accrued but unused vacation, in accordance with the Company&#146;s practices. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top">Your entitlement to any outstanding equity compensation awards will be determined by the terms of such equity compensation award agreements and the terms of the equity plans under which such awards were granted, subject
further to the Company&#146;s policies on compliance with securities law. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will only be entitled to receive the benefits in
Paragraph&nbsp;2(a)-(e)&nbsp;above if you sign this Letter Agreement and do not revoke any part of the general release and waiver of Claims in Paragraph&nbsp;3 within the 7-day revocation period described below, and if you do revoke any part of the
general release and waiver of Claims in Paragraph&nbsp;3, the Company will have no obligation to provide any payments to you as set forth in Paragraph&nbsp;2(a)-(e)&nbsp;above or otherwise. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>General Release and Waiver of Claims </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Release</U>. By signing this Letter
Agreement, you, on behalf of yourself and your heirs, executors, administrators and assigns, in consideration of the payments and benefits provided to you by the Company pursuant to this Letter Agreement, knowingly and voluntarily waive, terminate,
cancel, release and discharge forever the Company, its officers, directors, employees, members, attorneys and agents and their predecessors, successors and assigns, individually and in their official capacities (together, the &#147;<U>Released
Parties</U>&#148;) from any and all actions, causes of action, claims, allegations, rights, obligations, liabilities, or charges (collectively, &#147;<U>Claims</U>&#148;) that you (or your heirs, executors, administrators, successors and assigns)
has or may have, whether known or unknown, by reason of any matter, cause or thing occurring at any time before and including the date of this Letter Agreement arising under or in connection with your employment or termination of employment with the
Company, including, without limitation: claims for any cash or equity compensation or bonuses, whether or not paid under any Company compensation plan or arrangement; breach </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joseph Darling </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Separation and Release Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">December 9, 2014 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 of 8 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">of contract; tort; wrongful, abusive, unfair, constructive, or unlawful discharge or dismissal; impairment of
economic opportunity; defamation; age and national origin discrimination; sexual harassment; back pay; front pay; benefits; attorneys&#146; fees; whistleblower claims; emotional distress; intentional infliction of emotional distress; assault;
battery, pain and suffering; punitive or exemplary damages; violations of the Equal Pay Act, Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Age Discrimination in Employment Act of 1967 (&#147;<U>ADEA</U>&#148;), the
Americans with Disabilities Act of 1991, the Employee Retirement Income Security Act, the Worker Adjustment Retraining and Notification Act, the Family Medical Leave Act, including all amendments to any of the aforementioned acts; and violations of
any other federal, state, or municipal fair employment statutes or laws, including, without limitation, violations of any other law, rule, regulation, or ordinance pertaining to employment, wages, compensation, hours worked, or any other matters
related in any way to your employment with the Company or the termination of that employment. In addition, in consideration of the provisions of this Letter Agreement, you further agree to waive any and all rights under the laws of any jurisdiction
in the United States, or any other country, that limit a general release to those claims that are known or suspected to exist in your favor as of the Termination Date. This release of Claims will not, however, apply to any obligation of the Company
pursuant to this Letter Agreement, any rights to indemnification from the Company you may have, any rights to continuing directors&#146; and officers&#146; liability insurance to the same extent as the Company covers its other officers and
directors, any rights that you may have to obtain contribution in the event of the entry of judgment against yourself as a result of any act or failure to act for which both you and the Company are jointly responsible or any benefit to which you are
entitled under any tax qualified pension plan of the Company or its affiliates, COBRA continuation coverage benefits, vested benefits under any other benefit plans of the Company or its affiliates or any other welfare benefits required to be
provided by statute, and any claims which may not be released under applicable law (claims with respect thereto, collectively, &#147;<U>Excluded Claims</U>&#148;). For the avoidance of doubt, you shall remain covered under directors&#146; and
officers&#146; liability insurance and your indemnification agreement or policy for acts or omissions occurring during your period of providing services to the Company and any of its affiliates, including the 90-day period referenced in Paragraph 5
of this Letter Agreement, to the extent such coverage is permitted under the Company&#146;s policies and your indemnification agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>The Company knows of no claims held by the Released Parties against you</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Proceedings</U>. You further agree, promise and covenant that, to the maximum extent permitted by law, neither you, nor any person,
organization, or other entity acting on your behalf, has filed or will file, charged or will charge, claimed or will claim, sued or will sue, or caused or will cause, or permitted or will permit to be filed, charged or claimed, any action for
damages or other relief (including injunctive, declaratory, monetary or other relief) against the Released Parties with respect to any Claims other than Excluded Claims. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Acknowledgements by You</U>. You hereby acknowledge and confirm that you were advised by the Company in connection with your
termination of employment or services to consult with an attorney of your choice prior to signing this release and waiver of Claims, including, without limitation, with respect to the terms relating to your release and waiver of Claims arising under
ADEA, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joseph Darling </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Separation and Release Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">December 9, 2014 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 4
 of 8 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and that you have in fact consulted an attorney. You have been given twenty-one (21)&nbsp;days to review this
release and waiver of Claims, and you are signing this release and waiver of Claims knowingly, voluntarily and with full understanding of its terms and effects, and you voluntarily accept the benefits provided for under
Paragraph&nbsp;2(a)-(e)&nbsp;of this Letter Agreement for the purpose of making full and final settlement of all claims referred to above. You also understand that you have seven (7)&nbsp;days after the Termination Date to revoke the release and
waiver of Claims in this Paragraph&nbsp;3, and that this release and waiver of Claims and any obligations that the Company has under Paragraph&nbsp;2(a)-(e)&nbsp;of this Letter Agreement will not become effective if you exercise your right to revoke
the release and waiver of Claims within seven (7)&nbsp;days of execution. You understand that such revocation must be delivered to the Company at its headquarters, attn: General Counsel, during such period to be effective. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Non-Competition and Non-Disclosure </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You agree and acknowledge that your obligations
under the Agreement relating to Inventions, Trade Secrets, and Confidential Information with Covenant Not to Compete dated April&nbsp;15, 2008 (&#147;<U>Confidentiality Agreement</U>&#148;) will continue to apply after the Termination Date for the
period of time specified in such agreement; <U>provided</U>, that, (1)&nbsp;the Company waives the post-employment restrictions set forth in paragraph 14 thereof, and (2)&nbsp;you may disclose confidential or proprietary information of the Company
to the extent required by law or by any court, arbitrator, or administrative or governmental body, or as reasonably necessary in any legal, arbitration, administrative or governmental proceeding. You affirm that the Confidentiality Agreement does
not unduly burdensome to you and are reasonably necessary to protect the legitimate interests of the Company. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Cooperation and Representation </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You agree to, during the ninety (90)&nbsp;days after the
Termination Date, reasonably cooperate with the Company and its affiliates and their respective directors, officers, attorneys and experts, and take all actions the Company may reasonably request, to assist in the orderly transition of your pending
work to other officers or employees of the Company as may be designated by the Company. Such requests shall take into account any of your personal and business commitments and you shall be reimbursed (within thirty (30)&nbsp;days of providing an
invoice to the Company) for any reasonable expenses incurred in connection with such cooperation. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Other Terms </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Breach</U>. You agree and acknowledge that should you violate any
term of this Letter Agreement, the amount of damages that the Company would suffer as a result of such violation could be difficult to ascertain and money damages might not afford the Company an adequate remedy. You further agree and acknowledge
that in the event of your material breach of any material term of this Letter Agreement, the Company&#146;s obligation to provide you with any payments or benefits pursuant to Paragraph&nbsp;2(a)-(e)&nbsp;of this Letter Agreement will immediately
cease, and the Company will be entitled to seek recovery of monetary damages and seek to obtain all other relief provided by law or equity, including, but not limited to, injunctive relief. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joseph Darling </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Separation and Release Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">December 9, 2014 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 5
 of 8 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Additional Representations and Nondisclosure</U>. You acknowledge that you have not
relied on any representations or statements not set forth in this Letter Agreement. Except to the extent publicly disclosed by the Company or its representatives, you will not disclose the contents or substance of this Letter Agreement to anyone
except your immediate family, any lenders (for purposes of obtaining credit), your financial advisors or accountants and any tax, legal or other counsel that you have consulted regarding the meaning or effect hereof, and you will instruct each of
the foregoing not to disclose the same; <U>provided</U>, that you may disclose the contents or substance of this Letter Agreement to the extent necessary to enforce or implement its terms, as required by law or by any court, arbitrator, or
administrative or governmental body or to the extent appropriate in connection with any dispute over this Letter Agreement or otherwise involving you and the Company. Any such disclosure by any member of your immediate family, your financial
advisors or accountants or any of your tax, legal or other counsel will be regarded as a breach of this Paragraph&nbsp;6(b) by you, and you will be fully responsible for any such breach. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Non-disparagement</U>. You agree that you will not make or publish any statement (orally or in writing) that becomes or reasonably
could be expected to become publicly known, or instigate, assist or participate in the making or publication of any such statement, which would libel, slander or disparage (whether or not such disparagement legally constitutes libel or slander) the
Company or any other entity or person within the Company, any of their affairs or operations, or the reputations of any of their past or present officers, directors, agents, representatives or employees. The Company&#146;s Board of Directors will
not make any formal statement and will instruct the Company&#146;s executive officers not to make or publish any statement (orally or in writing) that becomes or reasonably could be expected to become publicly known, or instigate, assist or
participate in the making or publication of any such statement, which would libel, slander or disparage (whether or not such disparagement legally constitutes libel or slander) you. This Paragraph&nbsp;6(c) shall not be violated by making any
truthful statement to the extent required by law or by any court, arbitrator, or administrative or governmental body or to the extent appropriate in connection with any dispute over this Agreement or otherwise involving you and the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Nonadmission</U>. Nothing contained in this Letter Agreement will be deemed or construed as an admission of wrongdoing or liability on
the part of the Company or any of the other Released Parties or by you. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Entire Understanding</U>. This Letter Agreement sets forth
the entire agreement between you and the Company regarding your termination of employment and other service relationships with the Company, and supersedes any other severance, separation and/or employment agreements between you and the Company
(including, without limitation, your Executive Severance Agreement with CONMED Linvatec dated May&nbsp;1, 2008 and your Change in Control Severance Agreement with the Company dated May&nbsp;3, 2010) other than the Confidentiality Agreement (as
modified herein). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Governing Law</U><I>. </I>This Letter Agreement will be governed by and construed in accordance with the laws of
the State of New York applicable to agreements made and to be performed entirely within such State. If any provision in this Letter Agreement is held invalid or unenforceable for any reason, the remaining provisions will be construed as if the
invalid or unenforceable provision had not been included. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joseph Darling </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Separation and Release Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">December 9, 2014 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 6
 of 8 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Severability; Counterparts</U>. The invalidity or unenforceability of any provision of
this Letter Agreement will not affect the validity or enforceability of any other provision. If any provision of this Letter Agreement is held invalid or unenforceable in part, the remaining portion of such provision, together with all other
provisions of this Letter Agreement, will remain valid and enforceable and continue in full force and effect to the fullest extent consistent with law. This Letter Agreement may be executed in several counterparts, each of which will be deemed an
original, and such counterparts will constitute one and the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Section&nbsp;409A of the Code</U>. It is the
parties&#146; intent that the payments and benefits provided under this Letter Agreement be exempt from the definition of &#147;non-qualified deferred compensation&#148; within the meaning of Section&nbsp;409A of the Code (including as
&#147;separation pay&#148; pursuant to Treas. Reg. &#167;1.409A-1(b)(9)(iii)), and the Letter Agreement shall be interpreted accordingly. To the extent that any payment or benefit under this Agreement constitutes &#147;non-qualified deferred
compensation&#148; then this Letter Agreement is intended to comply with Section&nbsp;409A of the Code and the Letter Agreement shall be interpreted accordingly. In this regard each payment under this Letter Agreement shall be treated as a separate
payment for purposes of Section&nbsp;409A of the Code. If and to the extent that any payment or benefit is determined by the Company (a)&nbsp;to constitute &#147;non-qualified deferred compensation&#148; subject to Section&nbsp;409A of the Code and
(b)&nbsp;such payment or benefit must be delayed for six (6)&nbsp;months from your date of termination (or an earlier date) in order to comply with Section&nbsp;409A(a)(2)(B)(i) of the Code and not cause you to incur any additional tax under
Section&nbsp;409A of the Code, then the Company will delay making any such payment or providing such benefit until the expiration of such six (6)-month period (or, if earlier, your death or a &#147;change in control event&#148;, as such term is
defined in Section&nbsp;1.409A-3(i)(5) of the Code). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Death</U>. In the event of your death, any amounts that remain due to you
pursuant to this Letter Agreement will be paid to your estate or beneficiaries at the time such amounts would otherwise have been paid to you. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <U>Successors</U>. This Letter Agreement will be binding on and inure to the benefit of the Company&#146;s successors and assigns and, for
the avoidance of doubt, will survive a change in control of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) The Company shall reimburse you for, or pay directly,
reasonable legal fees (up to $15,000) in connection with the negotiation and execution of this Letter Agreement. Such payment shall be made within thirty (30)&nbsp;days of the Company&#146;s receipt of an invoice for such amounts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) You agree to return all Company property and any confidential information and proprietary data (regardless of the medium in which it is
memorialized), <U>provided</U>, that the Company agrees that you are permitted to retain your contact lists and calendars, computers, cell phone and cell phone number and copies of materials relating to your compensation and otherwise containing
data reasonably needed for tax purposes. You understand and agree that the Company will remove all data from the computer and cell phone before the Termination Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I>[<I>Remainder of Page Left Intentionally Blank</I>]<I> </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To indicate your agreement with the foregoing, please sign and return this Letter Agreement to
Heather L. Cohen, Executive Vice President Human Resources 525&nbsp;French Road, Utica, New York 13502. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">C<SMALL>ONMED</SMALL> C<SMALL>ORPORATION</SMALL></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Heather L. Cohen</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Heather L. Cohen</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Executive Vice President &#150; HR</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Accepted and Agreed:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Joseph Darling</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Joseph Darling</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date:</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">December&nbsp;9, 2014</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I>[<I>Signature Page to Letter Agreement re Separation and Release</I>]<I> </I></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joseph Darling </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Separation and Release Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">December 9, 2014 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 8
 of 8 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CONMED Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: EVP HR </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">525 French Road </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Utica, New York 13502 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Heather, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This letter shall serve to confirm that since January&nbsp;1, 2015 I am and have not been employed, whether as an employee, consultant, agent,
independent contractor or in any other capacity, since I was employed at Conmed Corporation. I agree to notify you when I am employed within three (3)&nbsp;business days of such an event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Sincerely, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">/s/ Joseph Darling </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Joseph Darling </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>d834990dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="42%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g834990img001.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="3" VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><B>NEWS RELEASE </B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><B>CONTACTS</B>:<B></B><BR> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"><B><I>CONMED&nbsp;Corporation</I></B></P>
<P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"><B>Robert Shallish</B></P>
<P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"><B>Chief&nbsp;Financial&nbsp;Officer</B></P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"><B>315-624-3206</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><B><I>Joele&nbsp;Frank,&nbsp;Wilkinson&nbsp;Brimmer&nbsp;Katcher</I></B><BR> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"><B>Andy Brimmer / Jamie Moser</B></P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"><B>212-355-4449</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONMED Corporation Announces Management Transitions </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Robert Shallish to Retire as Executive VP, Finance and CFO Effective March&nbsp;31, 2015; Luke Pomilio Appointed Executive VP, Finance and
CFO Effective April&nbsp;1, 2015 </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>John Hamilton to Retire as Vice President of CONMED International Effective February&nbsp;28,
2015; Patrick Beyer Appointed President of CONMED International Effective Immediately </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Joseph Darling Leaving Company With
Elimination of the Position of Executive VP and Chief of Commercial Operations Effective December&nbsp;31, 2014 </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>UTICA, New York, December&nbsp;09,
2014 </B>&#150; CONMED Corporation (NASDAQ: CNMD) today announced a number of management transitions. After 25 years of service, Robert D. Shallish, Jr., Executive Vice President, Finance and Chief Financial Officer, recently informed the Company of
his plan to retire on March&nbsp;31, 2015. Luke Pomilio, Controller, has been appointed Executive Vice President, Finance and Chief Financial Officer of the Company, effective April&nbsp;1, 2015. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;On behalf of the Board of Directors and everyone at CONMED, I want to thank Rob for his leadership and contributions to the growth and success of our
Company,&#148; said Curt Hartman, President and Chief Executive Officer of CONMED. &#147;Rob has significantly strengthened CONMED&#146;s finance organization and investor relations program, and during his 25-year tenure the Company grew from
roughly $30 million to more than $700 million in sales. Rob has also been an important resource for me during my transition and I am confident that he will oversee a seamless process as Luke takes on his responsibilities. We wish Rob all the
best.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Robert Shallish said, &#147;CONMED has been an important part of my life for the past 25 years and I feel fortunate to have worked alongside
such talented professionals. I am confident that under Curt&#146;s leadership CONMED&#146;s prospects are bright and I look forward to working with Luke over the next four months to ensure an orderly transition. I have had the pleasure of working
with Luke for almost 20 years and I am confident that he will excel as the Company&#146;s next CFO.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Luke Pomilio said, &#147;I look forward to
continuing to work with CONMED&#146;s management team as we seek to position CONMED for its next phase of growth and success. I will focus on driving continued growth and shareholder value creation.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company also announced that Patrick Beyer, former CEO of ICNet and former head of Stryker Europe, has been appointed President of CONMED International,
effective immediately. John Hamilton, Vice President of CONMED International, will retire from the Company effective February&nbsp;28, 2015. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Hartman added, &#147;I am pleased to welcome Pat to CONMED and look forward to working with him as he
leads the continued growth of our international businesses. I also want to thank John &#150; a 25 year CONMED veteran &#150; for his many years of substantial contributions that have favorably positioned the international business of CONMED in the
markets we serve.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company also announced that Joseph Darling will be leaving the Company following the elimination of his position as Executive
Vice President, Commercial Operations effective December&nbsp;31, 2014. Mr.&nbsp;Darling&#146;s responsibilities will be realigned and redistributed to senior executives within the CONMED organization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Hartman continued, &#147;I want to thank Joe for his many contributions to CONMED, principal among them his focus on growing and expanding the sports
medicine offering. We greatly appreciate Joe&#146;s six years of service and wish him continued success in his future endeavors.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Luke
Pomilio </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Luke Pomilio joined CONMED as Controller in September 1995. Subsequently, Mr.&nbsp;Pomilio assumed additional responsibility for certain
corporate functions including worldwide operations and select administrative functions. In May 2009, Mr.&nbsp;Pomilio was promoted to Vice President, Controller and Corporate General Manager. In March 2013, Mr.&nbsp;Pomilio was promoted to Executive
Vice President, Controller and Corporate General Manager. Prior to his tenure with CONMED, Mr.&nbsp;Pomilio was a manager with Price Waterhouse LLP. Mr.&nbsp;Pomilio is a certified public accountant and graduated with a B.S. degree in Accounting
from Clarkson University. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Patrick Beyer </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pat
Beyer was most recently&nbsp;CEO&nbsp;of&nbsp;privately held&nbsp;ICNet International, Ltd. from December 2010 until August 2014 where he presided over successful strategic development and growth, ultimately leading to the sale of the company to a
multinational healthcare firm. From 2005-2009, Mr.&nbsp;Beyer served as President&nbsp;of&nbsp;Stryker Europe, and from 2002-2005 he led Stryker UK, South Africa and Ireland. Prior to that, he was Vice President and&nbsp;General Manager for Stryker
Medical. His tenure in all positions was marked by strong growth and commercial development. Mr.&nbsp;Beyer has an MBA in Finance from Western Michigan University, and BA from Kalamazoo College. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About CONMED </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CONMED is a medical technology company with
an emphasis on surgical devices and equipment for minimally invasive procedures. The Company&#146;s products are used by surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery and
gastroenterology. Headquartered in Utica, New York, the Company&#146;s 3,600 employees distribute its products worldwide from several manufacturing locations. CONMED has a direct selling presence in 16 countries outside the United States and
international sales constitute more than 50% of the Company&#146;s total sales. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking
statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company&#146;s performance on a going-forward basis. The forward-looking statements in this press release involve
risks and uncertainties which could cause actual results, performance or trends, to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. In addition to general industry and economic conditions,
factors that could cause actual results to differ materially from those discussed in the forward-looking statements in this press release include, but are not limited to&nbsp;the risks relating to forward-looking statements discussed in the
Company&#146;s Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2013. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g834990img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g834990img001.jpg
M_]C_X``02D9)1@`!`0$!+`$L``#_X@Q824-#7U!23T9)3$4``0$```Q(3&EN
M;P(0``!M;G1R4D="(%A96B`'S@`"``D`!@`Q``!A8W-P35-&5`````!)14,@
M<U)'0@``````````````````]M8``0````#3+4A0("``````````````````
M`````````````````````````````````````````````!%C<')T```!4```
M`#-D97-C```!A````&QW='!T```!\````!1B:W!T```"!````!1R6%E:```"
M&````!1G6%E:```"+````!1B6%E:```"0````!1D;6YD```"5````'!D;61D
M```"Q````(AV=65D```#3````(9V:65W```#U````"1L=6UI```#^````!1M
M96%S```$#````"1T96-H```$,`````QR5%)#```$/```"`QG5%)#```$/```
M"`QB5%)#```$/```"`QT97AT`````$-O<'ER:6=H="`H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0``9&5S8P`````````2<U)'0B!)14,V,3DV
M-BTR+C$``````````````!)S4D="($E%0S8Q.38V+3(N,0``````````````
M````````````````````````````````````````````````````6%E:(```
M`````/-1``$````!%LQ865H@`````````````````````%A96B````````!O
MH@``./4```.06%E:(````````&*9``"WA0``&-I865H@````````)*````^$
M``"VSV1E<V,`````````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````
M````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````````````````````
M``````````````````````````````````!D97-C`````````"Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M('-21T(`````````
M`````"Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M
M('-21T(`````````````````````````````9&5S8P`````````L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0``````````
M````+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$``````````````````````````````````'9I97<``````!.D_@`47RX`
M$,\4``/MS``$$PL``UR>`````5A96B```````$P)5@!0````5Q_G;65A<P``
M```````!`````````````````````````H\````"<VEG(`````!#4E0@8W5R
M=@````````0`````!0`*``\`%``9`!X`(P`H`"T`,@`W`#L`0`!%`$H`3P!4
M`%D`7@!C`&@`;0!R`'<`?`"!`(8`BP"0`)4`F@"?`*0`J0"N`+(`MP"\`,$`
MQ@#+`-``U0#;`.``Y0#K`/``]@#[`0$!!P$-`1,!&0$?`24!*P$R`3@!/@%%
M`4P!4@%9`6`!9P%N`74!?`&#`8L!D@&:`:$!J0&Q`;D!P0')`=$!V0'A`>D!
M\@'Z`@,"#`(4`AT")@(O`C@"00)+`E0"70)G`G$">@*$`HX"F`*B`JP"M@+!
M`LL"U0+@`NL"]0,``PL#%@,A`RT#.`-#`T\#6@-F`W(#?@.*`Y8#H@.N`[H#
MQP/3`^`#[`/Y!`8$$P0@!"T$.P1(!%4$8P1Q!'X$C`2:!*@$M@3$!-,$X03P
M!/X%#04<!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&
M609J!GL&C`:=!J\&P`;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E
M!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)
MN@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X`+F`NP
M"\@+X0OY#!(,*@Q##%P,=0R.#*<,P`S9#/,-#0TF#4`-6@UT#8X-J0W##=X-
M^`X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[!`)$"800Q!A
M$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3
M(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/`5$A4T%585>!6;%;T5X!8#
M%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$`891B*&*\8U1CZ&2`9
M11EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H<`APJ'%(<>QRC
M',P<]1T>'4<=<!V9'<,=[!X6'D`>:AZ4'KX>Z1\3'SX?:1^4'[\?ZB`5($$@
M;""8(,0@\"$<(4@A=2&A(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"(_`D'R1-
M)'PDJR3:)0DE."5H)9<EQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH#2@_*'$H
MHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K`BLV*VDKG2O1+`4L.2QN+*(LURT,
M+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<O_C`U,&PPI##;,1(Q2C&",;HQ
M\C(J,F,RFS+4,PTS1C-_,[@S\30K-&4TGC38-1,U336'-<(U_38W-G(VKC;I
M-R0W8#><-]<X%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\
M93RD/.,](CUA/:$]X#X@/F`^H#[@/R$_83^B/^)`(T!D0*9`YT$I06I!K$'N
M0C!"<D*U0O=#.D-]0\!$`T1'1(I$SD42155%FD7>1B)&9T:K1O!'-4=[1\!(
M!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I-`DU*39--W$XE
M3FY.MT\`3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4
MVU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N5
M6^5<-5R&7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB
M\&-#8Y=CZV1`9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(
M:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R
M2W*F<P%S77.X=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&
M>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$>`J($*@6N!S8(P@I*"
M](-7@[J$'82`A..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6
MB_R,8XS*C3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4
M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY`
MGJZ?'9^+G_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H
M4JC$J3>IJ:H<JH^K`JMUJ^FL7*S0K42MN*XMKJ&O%J^+L`"P=;#JL6"QUK)+
MLL*S.+.NM"6TG+43M8JV`;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]
M%;V/O@J^A+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_
MR#W(O,DZR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'3
M1-/&U$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N`W`7<BMT0W9;>'-ZB
MWRG?K^`VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJ
MY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[
M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____VP!#``@%!@<&!0@'
M!@<)"`@)#!,,#`L+#!@1$@X3'!@='1L8&QH?(RPE'R$J(1H;)C0G*BXO,3(Q
M'B4V.C8P.BPP,3#_VP!#`0@)"0P*#!<,#!<P(!L@,#`P,#`P,#`P,#`P,#`P
M,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,##_P``1"``Z`.\#
M`2(``A$!`Q$!_\0`'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`
MM1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*Q
MP152T?`D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA9
M6F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*S
MM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ
M_\0`'P$``P$!`0$!`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#
M!`<%!`0``0)W``$"`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1
M"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI
M:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZ
MPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1
M`Q$`/P#F_&GCKQ59^,=;M;;7KZ*""_GCCC67`11(P`'L`*R/^%A^,/\`H8M0
M_P"_IJM\0/\`D>_$/_82N?\`T:U85(9TW_"P_&'_`$,6H?\`?TT?\+#\8?\`
M0Q:A_P!_37-QH\LB1Q(TDCL%55&2Q/0`>M>M>"?@S)+:#5_&MQ_9MBB^<;;<
M%<H`23(QXC'`XY."?ND4P.9T/Q/\0]?O!:Z/JFKWDO&1$Y(0$XRQZ*/<D"M2
M_P#%>N^&V,6K^+;O4]30X:QL[D^5"<`XEEQR0<@HGH?G!IOC7XDQ&RE\.^![
M5-*T0$HTL:;)+@<@GV4\=?F/<C)%>;T@.HD^(OB]Y&9=?OHU8DA%F.%]AG)_
M,U]%_"+4+O5?AYI5[J-Q)<W,HEWRR'+-B5P,GZ`"ODP=:^JO@?\`\DNT7Z3?
M^CGIB.V/%>4>-OC+#9ZA_9'@ZS&M:@QV>8H9HU?.-JJO,AX/0@=,$\U/\?\`
MQ9-HGA^'2+!V6\U4LC,O580,,![L2!]-U;'PG\!VW@_18YKB(-K%U&#=2M@F
M///E*1V'?'4C/88`.'CE^-]\@GB5;5&Z(4MD/Y-R/QID?Q-\<^#M0A@\=Z/Y
MMH[X,RQ!&(P,['4^6Q`YQU]Q7N=5=4TVSU:PFLM1MX[BWF7:Z.,@C^A]^U`"
MZ9>PZEIMK?VI+07423QDC!*L`1Q]#5FO/_'WCBP^&^B6.EZ?;_:KWR5AM;8N
M?D11M5G/7'&,=6P>1R1S-CX?^*/C$QW^K>('\.6LIW+!`7CDC7!(^12#U.,.
M^[UZ"@#V:BO%+FP^*_@>W-]%JD?B"SB.9(&+3OMYY(8!^_\`"WZ"NMT'QYI_
MCCP3K$ELC6]W;V<@N+=R"5)C;E3W4D'!Z\<@4`=]17C/P:^*IOS!X>\33#[7
MQ':WCG_7>B.?[_H?XNAY^][,.:`"BN1^+VI7FD?#O5;[3;A[:ZB\G9+&<,N9
MD!Q^!(K,\">)+X_!P:_J5R;J[@M[J8R2\ERC2;0>F?N@4`6?A=XR7Q0VN6[2
M;WL;^7RF/!:W=B8^O/&".@X`KN*^4OA%XD?PKXRLKFX/EV%]FUG9CA=K'[V3
MQ\K`$GTSZU]6@YH`*XCP_P",O[6^)^MZ!#(KVMC:ILV\YD5L2'/UD52/]CCO
M6UX\\0Q^%O"E_JS[3)#'B%#_`!R'A![C)&<=@:^>_@=J,UK\3K%IBS?;TEC=
MVR2V5+9]_F4?K0!]0T5Y7\9/%'B71?$&@Z;X:U%;-M2S&=T,;@N755)+*2!S
MVIG]B?&?_H:=(_[])_\`&*`/5Z*\.\<Z]\2/!.@6\FK:]:2W=U=%8Y+>"-@(
MPO*D&,#J<]*NW%M\;;58I8]0L[X,F]D1+<;3C[IRB\_0D>]`'K.IW;VL*>3&
M))97"(&)"]"220#C"@GW(`[U@>&?$\VIH)Y9+:YM&<Q^?;*,1MMW#)225<'!
M!RP(.T;?F!KA-'^*<]WJ46B>.+#^PM2CDW6]T498D<JRCS$8YVD,1G.#G^'[
MP]-M='=KKS[V:&51L9$AC:-2X0H68%V#<$X&..,[B%(`/E3X@?\`(]^(?^PE
M<_\`HUJHZ#HU_K^JP:;I<#3W,[851T`[L3V`[FM/QI;37GQ&UNUM8FEGFU6>
M..-!DLQE8`#\:^BOA5X$@\%Z&%F"2ZI<@/<S8'RG'^K4_P!T?J<GT`0RK\-?
MAAIOA"V2YNQ'?ZNP!>X9`5B/I&#R/KU/MTK@/VA?&DESJ!\*V1>."U*R7;!N
M)7(#*OT4'/N2./EKWVOF'XZ^&[K1O&UUJ!C<V6IMY\4N,C?CYT)]0<G'H13$
M>>T45K^'O"VN>(YQ%HNF7%T>[JN(UZ]7.%'0]3VI#,BOJGX'_P#)+M%^DW_H
MYZX[P/\``J"'R[SQ=<>?(.190-B,=>'?JW;@8Z=37L5E:6]A:1VME!';V\2[
M4CC4*JCT`%,1XA\60)?CGX7BE`:(FR!5AD8-PV17NM>1?M#^&[BYL;+Q+IJ/
M]HTPE9FC7YEBSN#Y]%8'_OHGM79_#;QG:>,?#L%TDB"^C4)=P9`9)`.3C/W3
MU!_J#0!U5%%1W$T5O"\T\BQ1H-S.YP%'J30!XA\.[9?''Q?UOQ!J"F:WTV3-
MNKX^0[BL.1[*K'C^+GZ^YUX5\-[Z+P?\7M;T6]<6UIJ;M]F+,"K98O"=Q]48
M@<]2!UZ>ZT`!&:^?/&\">`_BO*VFDK::[:N)(%'`\W<A')Z;P']N@''/T&3C
MK7SU\0)QXW^+#1:7S!HEL3+.`2"(2SM^&X[![\]*`,#X?>`AXV\,ZRUHP34[
M*2-H"QPK@JVY#Z9P,'MCW->G_"CXC375P/"WBW=;:W;'R4>4;?.Q_"?]O_T+
MZ]<O]F#_`(\M?_ZZP?R>NH^*WPXB\5VW]H:5MMM;ME'E2`[?.`Z*Q]?0]OIT
M!EGXY_\`)+-9_P"V'_H^.O/I-1%A^S/;QAMKWDS6Z\CO<.QZ]?E1JI:IX^NM
M5^&&N^&_%1,&NVGDJ@E&UYU$Z9R/[Z@9/J.>Q-8/B:^?_A4G@[3(^1--=SLH
MSDE92J^W\;4`=%K'@=I_@3H^I);A;_3U>];:!F2"5R23CJ0FQLGH%(KU+X0^
M(CXD\"V-Q-)YEU;YM;@XZNF,$^I*E3^-=#INEV]IH5MI7E(UM#;K;>6PW*4"
M[<'/7BO#O!VKQ?"SXB:_HFH2/_9;QO+'N89.Q3)%R<`L4)7CJQ`H$7_COJ=U
MXA\5:1X*TMPQ=T>4#)'F.<+N`Z!5RQ]FSVK.^+5@G@GQGX2U&U1C965O#&NW
M[S^1)ENF`20R_4D]*U/@/I<_B'Q)JWC?5%#2-,\<'.0LC\N5SR-JD*/9B.U:
MG[2UB9O">GWJ@'[->;&X&0KJ><_51Q[^U`S.^/%Y!9^-/!][</MMX)!,[`9P
MHD0D\=>!76_\+F\$?]!.;_P%E_\`B:\[\<W4>MW?PSFN&2Z6YA@6;=A@[;XP
MX;L><@CZU[+_`,(5X5_Z%K1__`&+_P")H$>0_'+Q/I7BOPII5]HD[3V\=])"
MS-&R8<(I(P0#T85[S'_JU^@KQ3]HG3+#2?#FCP:796UE"UW(YCMXEC4L5'.`
M`,\#\J]KC_U:_04`<%\</#%OKO@J[O`B+>:6C744A'.U1EUSUP5SQZ@5:^#&
MMSZ[\/K":[+//;;K5W;^/8<*??Y=N3ZYI?C)KMKHG@#4A<$&6^B:SACS@LS@
M@G\!D_ACO5;X$Z;/IOPYL3<J4:[=[E5(P0K'"_F`&_&@#C/ACHD6H?&GQ5J-
MQ&DBZ==W!CW$Y65YF`('0_*'^G'X>X5X!X&\36WA[XV>(X=0N/(M-1O+F#)^
MZ)?/)0L>P^\,_P"U^->_T`%1W-O#=0M#<PQS1-U210RGOR#4E%`&?_8.C_\`
M0)L?_`=/\*O11QQ1K'$BHB`*JJ,!0.@`IU%`!17-^+/'GAWPHA_M;4$$Y!*V
MT7[R5NO\(Z=",G`SWJ]X2U^#Q/X?MM8M(I(8+DOL27&X!79><<<[<_C0!JNB
MNA5U#*PP01D$5Y/XJ^#TBZF^L>!=3;1[QCN,.]DCSQ]UEY49&<'(SZ"O2M6@
MNID1K74SIZIDNPC1PW3KN'&/ZU2CT[594#Q>)I'4]"MM"1_*@#R^*X^-UI$L
M'V2.XV#'F.;=B?J=PS40\`?$3QI<[O&>L-8V+,"UNL@;I@C$:?)^).>.]>K'
M2]8'7Q'-_P"`L7^%-BL-4F4M#XG>0`X)6VA(S^5`&7X\^'>F>+]'AM96-M>6
MJ!8+L(&90.S=-P]N/:N%LS\7?!D)LXK6#7[.W3Y)&/G'!YP/F61B.F#GKZ`8
M]1_LK6?^ACF_\!(O\*/[+UC_`*&.;_P$B_PH`\NN[;XM>-UAM[V*'P]ITH!D
M,9\HD=>1N:3/^SD#UKN=!\!V'A7P=?:;I,0GO;BUD62X8`23N4(QGLN>BYP/
M<Y)V/[*UG_H8YO\`P$B_PH_LO6/^ACF_\!(O\*`.(^`GA76_"]IJZ:]8M9M<
M/$T8,B/N`#9^Z3ZBO4:Q3I>L#KXCF_\``2+_``H_LO6#_P`S'-_X"1?X4`<]
M\4_AU9>+]-DN;6-8-9@0M!,H`\W`XC?U!Z`G[O7ID'RSP=X'\1ZIJ_A:>YTF
M>WT[2W,<\LI0<I<RR,-F[=U.WIZU[I_96L?]#'-_X"1?X4?V7K'_`$,<W_@)
M%_A0!M5Y3\?/!3Z[96&J:7;A[^&9+5PH`+QR-M7)]G(_!FKO/[*UG_H8YO\`
MP$B_PH_LK6/^ACF_\!(O\*`+'AG1+7P[H5GI-B"(+6,(">K'J6/N22?QK&^+
M&D3ZY\/]6LK.![BY,:R11H`69D<-@>^`1@<GIWK1_LK6?^ACF_\``2+_``H_
MLK6?^ACF_P#`2+_"@#P&ZT3Q;'H7A)K?PYJ#76C23-L:VD;)\X2*6``(!SC'
M^S76?\+#^*W_`$)B?^"ZX_\`BZ]2_LO6/^ACF_\``2+_``H_LK6?^ACF_P#`
M2+_"@#QOQ]_PFGC7P;82ZGX<N(K^#4)5\BVM)5Q%Y:$,58D\L6&>G%:T/C7X
MM7[-;VOA&&W8H</):21[>.H9Y`N?0']:]-_LO6/^ACF_\!8O\*7^RM9_Z&.;
M_P`!(O\`"@#SCPS\+M9U[5$UOXE7[W<@^9+'?D`Y'#;?E4<?=7@\<]0?7XXT
MBC6.-51$`5548``Z`"L?^R]8_P"ACF_\!(O\*UK='C@C2:4S2*H#2$`;SZX'
M`H`^0/B!_P`CWXA_["5S_P"C6KKO!7QHUOP_:QV6IPKJ]K&?E:1RLRKCIOYR
M![@GMGICZ%DT+1YI'DFTJQDD=BS,UNA+$]23CK3?^$>T3_H#Z?\`^`R?X4`>
M>VGQ[\,20J;FRU2&3:-RB)&`/<`[^1[D"G2?'OPHAPMGJ\G'58(_ZR"N_P#^
M$>T3_H#Z?_X#)_A1_P`(]HG_`$!]/_\``9/\*!GC>J_M!W3Q[=)T*&)_[]S,
M9!W_`(5"^W>N%\0?$_Q=KK,)]6EM8B21#9_N5`/;(^8CZDU]/_\`"/:)_P!`
M?3__``&3_"C_`(1[1/\`H#Z?_P"`R?X4"/C'J<FOJKX(?\DNT7Z3?^CGKI#X
M>T3!_P")/I__`(#)_A5VUMX;6!8;6&.&)/NI&H51SG@"@#FO%/V9O$^CQ:R$
M.DO'.,3_`.I:ZS&(@V>"=IDVAN,].<5MZ/%I4*3QZ,EHB"3]\ML%`$FU>H7O
MMV_ABKD\:30O%*BR1N"K(PR&!'(([BF6EM;V<0AM((H(ADA(D"J/P%`&!XU:
M$2:2FH[QI4EWLO/^>9!C<()?]@OM'/!.T'@U5<:=:>,=(A\/16L<LBR_;DM5
M4`6^PE6<+_TT"!2>>6Q_%76RJKQLKJ&5A@@C((J"SLK2Q4QV5K#;(QW%88P@
M)]<#Z4`5_$W_`"+>J?\`7I-_Z`:XOX+)*=+:6:"*R;[%91BVC_C419%PW0%I
M`V"?^F>TDE37H<BJ\;(ZAE88((R"/2H+>TMH9%>&WBC94$2LJ`$(,X4>P].E
M`'/?%-2W@JX58TD9KFS`1SA6_P!*BX)P>#]#5WP?I-UI%G=K=B"(W-R]PEM;
M,6AME./D0D`D$@L>`,L<"MFXABGCV31I(F0=KJ",@Y!P?0@&I!TH`YSQ3Y$^
MK:59:L4&DW'FF19#B.69=GE1OG@J096P>"47Z&O:VT&F^-X+/0;>*"UDLY9=
M0BA7;&C;T\EMH^4.V91G@L%.<[1CI+VUM[VV>WO((KB"08>.5`ZL/<'@U%I>
MG6.F0M;Z;9V]G#N+>7;Q+&N?7``%`%#QY_R(^O\`&?\`B6W/_HIJR_ARF%U1
MQ:0Z6IN=@TJ%@19E5`.0``"Y^?Y1@@J><DGJ[F&*XMY(+B-)895*/&ZAE=2,
M$$'J".U1P6T$=U-<1P1I/-@22*@#/MZ;CU.,G&:`,_Q?K#:'X?NKV&)KBZ`$
M=M`H),TS':B@#DY8C..V:POACJ;FWNM$O!J2W-FWG1MJ<92XGAD)/F,"3G]Y
MYB_0+77W-O#.T330QR-"_F1EU!*-@C</0X)&?0GUI#;0&]6Y,,9N%C,:R[1O
M"$Y*@]<$@''L*`.4^,5G;7'P_P!3EN+>*62W0/$[H&,;%E!*D]#CCBNLLK2V
ML+5+:QMXK:WC&$BB0(J]^`.!5+Q5!%<>&]1BN(DEC-NY*.H8'`R.#[@&M,=*
M`.8AEE/Q2NH#*_E#187$>X[0WGR@G'3.`.:L^/;N6S\+W,L5PUL&DABDG5MK
M11/*B2.&_A*HS'=VQGM5B"&+_A*[R?RT\W['`GF;1NV[Y3C/IGM6G*B2QM'*
MBNC@JRL,A@>H(H`Y+6K&ST"UTVXT',%W)>6\2*DS,;M7D17#@D^81%N;<<D!
M,Y`!KK^U<'X$TO3X?%6N/#86L;6<HBMRL*@PH6DRJ<?*#Z"N]H`X;1KW4-%L
M+B^OKF2]TB>YNO,=^7L2)G`/')BP!GNG7[N=G1>"Y'E\':))([.[V%NS,QR6
K)C7))[U-H**NE[54!3+,<`<<R-FI-!18]#T](U"(MM&%51@`!1P!0!__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g834990img003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g834990img003.jpg
M_]C_X``02D9)1@`!`0$!+`$L``#_X@Q824-#7U!23T9)3$4``0$```Q(3&EN
M;P(0``!M;G1R4D="(%A96B`'S@`"``D`!@`Q``!A8W-P35-&5`````!)14,@
M<U)'0@``````````````````]M8``0````#3+4A0("``````````````````
M`````````````````````````````````````````````!%C<')T```!4```
M`#-D97-C```!A````&QW='!T```!\````!1B:W!T```"!````!1R6%E:```"
M&````!1G6%E:```"+````!1B6%E:```"0````!1D;6YD```"5````'!D;61D
M```"Q````(AV=65D```#3````(9V:65W```#U````"1L=6UI```#^````!1M
M96%S```$#````"1T96-H```$,`````QR5%)#```$/```"`QG5%)#```$/```
M"`QB5%)#```$/```"`QT97AT`````$-O<'ER:6=H="`H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0``9&5S8P`````````2<U)'0B!)14,V,3DV
M-BTR+C$``````````````!)S4D="($E%0S8Q.38V+3(N,0``````````````
M````````````````````````````````````````````````````6%E:(```
M`````/-1``$````!%LQ865H@`````````````````````%A96B````````!O
MH@``./4```.06%E:(````````&*9``"WA0``&-I865H@````````)*````^$
M``"VSV1E<V,`````````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````
M````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````````````````````
M``````````````````````````````````!D97-C`````````"Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M('-21T(`````````
M`````"Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M
M('-21T(`````````````````````````````9&5S8P`````````L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0``````````
M````+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$``````````````````````````````````'9I97<``````!.D_@`47RX`
M$,\4``/MS``$$PL``UR>`````5A96B```````$P)5@!0````5Q_G;65A<P``
M```````!`````````````````````````H\````"<VEG(`````!#4E0@8W5R
M=@````````0`````!0`*``\`%``9`!X`(P`H`"T`,@`W`#L`0`!%`$H`3P!4
M`%D`7@!C`&@`;0!R`'<`?`"!`(8`BP"0`)4`F@"?`*0`J0"N`+(`MP"\`,$`
MQ@#+`-``U0#;`.``Y0#K`/``]@#[`0$!!P$-`1,!&0$?`24!*P$R`3@!/@%%
M`4P!4@%9`6`!9P%N`74!?`&#`8L!D@&:`:$!J0&Q`;D!P0')`=$!V0'A`>D!
M\@'Z`@,"#`(4`AT")@(O`C@"00)+`E0"70)G`G$">@*$`HX"F`*B`JP"M@+!
M`LL"U0+@`NL"]0,``PL#%@,A`RT#.`-#`T\#6@-F`W(#?@.*`Y8#H@.N`[H#
MQP/3`^`#[`/Y!`8$$P0@!"T$.P1(!%4$8P1Q!'X$C`2:!*@$M@3$!-,$X03P
M!/X%#04<!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&
M609J!GL&C`:=!J\&P`;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E
M!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)
MN@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X`+F`NP
M"\@+X0OY#!(,*@Q##%P,=0R.#*<,P`S9#/,-#0TF#4`-6@UT#8X-J0W##=X-
M^`X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[!`)$"800Q!A
M$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3
M(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/`5$A4T%585>!6;%;T5X!8#
M%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$`891B*&*\8U1CZ&2`9
M11EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H<`APJ'%(<>QRC
M',P<]1T>'4<=<!V9'<,=[!X6'D`>:AZ4'KX>Z1\3'SX?:1^4'[\?ZB`5($$@
M;""8(,0@\"$<(4@A=2&A(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"(_`D'R1-
M)'PDJR3:)0DE."5H)9<EQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH#2@_*'$H
MHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K`BLV*VDKG2O1+`4L.2QN+*(LURT,
M+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<O_C`U,&PPI##;,1(Q2C&",;HQ
M\C(J,F,RFS+4,PTS1C-_,[@S\30K-&4TGC38-1,U336'-<(U_38W-G(VKC;I
M-R0W8#><-]<X%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\
M93RD/.,](CUA/:$]X#X@/F`^H#[@/R$_83^B/^)`(T!D0*9`YT$I06I!K$'N
M0C!"<D*U0O=#.D-]0\!$`T1'1(I$SD42155%FD7>1B)&9T:K1O!'-4=[1\!(
M!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I-`DU*39--W$XE
M3FY.MT\`3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4
MVU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N5
M6^5<-5R&7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB
M\&-#8Y=CZV1`9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(
M:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R
M2W*F<P%S77.X=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&
M>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$>`J($*@6N!S8(P@I*"
M](-7@[J$'82`A..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6
MB_R,8XS*C3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4
M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY`
MGJZ?'9^+G_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H
M4JC$J3>IJ:H<JH^K`JMUJ^FL7*S0K42MN*XMKJ&O%J^+L`"P=;#JL6"QUK)+
MLL*S.+.NM"6TG+43M8JV`;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]
M%;V/O@J^A+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_
MR#W(O,DZR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'3
M1-/&U$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N`W`7<BMT0W9;>'-ZB
MWRG?K^`VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJ
MY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[
M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____VP!#``@%!@<&!0@'
M!@<)"`@)#!,,#`L+#!@1$@X3'!@='1L8&QH?(RPE'R$J(1H;)C0G*BXO,3(Q
M'B4V.C8P.BPP,3#_VP!#`0@)"0P*#!<,#!<P(!L@,#`P,#`P,#`P,#`P,#`P
M,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,##_P``1"``^`/H#
M`2(``A$!`Q$!_\0`'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`
MM1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*Q
MP152T?`D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA9
M6F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*S
MM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ
M_\0`'P$``P$!`0$!`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#
M!`<%!`0``0)W``$"`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1
M"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI
M:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZ
MPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1
M`Q$`/P#L?'7B_6](\37%G8721P(J%5,2M@E03R16%_PL'Q+_`,_T?_?A/\*7
MXH?\CI=_[D?_`*`*Y>O:I4:;IQ;BMCY?$8BK&K)*3W?4Z?\`X6#XE_Y_H_\`
MOPG^%'_"P?$O_/\`1_\`?A/\*YBMOPUX5U+Q#)FU016P.&N)!A1[#U/TJY4Z
M,%>21G"MB*CY8R;9<7X@>)F8`7J$G@`0+D_I6T->\66UHMWK6J0Z;`XRB/;J
MTTO^ZG]3BG:C-HG@-/LVFQ+?ZT5^::49$6>_M]!^)K@[^]N=1NGN;V9YYGZN
MQ_0>@]JRC"-36,4EZ'1.K.CI*;<NU]%ZG3W?Q$UQF"V=P(XU_BDC1G;W.!@?
M05N_#WQ7K&LZ^;74;E98?)9]HC5>01CD?6O-*['X2?\`(UG_`*]W_F*=:C3C
M3=D3AL35G6BI2>Y[#6#XS\7Z3X/TS[;J\Q!;*Q0IS),WHH_F>@K9NKB*UMI;
MB=@D4*&1V/90,D_E7S]X8TZX^,/Q"N]6U@N-&LB,19Q\F3LB'IG!+'Z^M>,?
M3&D/B'\1?&DK_P#"%Z,+2S!VB;8&_.1\+GV`IT\WQMT<?:95%\BC+1HL,O\`
MXZN#^5>VVEM!9VT=M:0I!!$H5(XU"JH]`!4M`'G/PM^)LOBZ_FT?5=,:RU.W
MC,CE,[&`(!&#RIY''->C5G_V)IPUP:RMLB:@(3`TRC!="0<-Z]!BO//%7Q+U
M._UY_#7P[L5U'4$)6:[<9BBQP<=N/[QX^M`'J=%>1#P7\5;D&>?QQ#!,W/E1
M[MH/IPH'Z5$OC;QI\/[V&#X@6B:EI<K!%U"U`ROUQ@'Z$`^F:`/8J*X+XI^)
MI;+X>Q^(/#MXI/GP2PS)RKJ6Z$=P1P16E\.?'5AXWTCSX,0WL(`N;4GF-O4>
MJGL:`.KHHKSWXY^(=5\->%K6[T2[-I.]VL;.%5LKM8XY![@4`=SJ=TMCIMU=
MR<);PO*?HH)_I7)_!WQ6WBOP=%-<R;[ZU8P7&3R2.5;\5(_$&F?%#57L_A/?
MW+O^^N;1(<^K28!_F:\?^`OB-M!\9QV%R2EIJZ"'YN!YG_+-OQ.5_&@#Z8HH
MKG/B-XC7PMX/O]3!`G">7;@]Y6X7\NOT%`&)X7\:_P!M_%'7='BDS9V5LJ0@
M'AG1L2'\VQ_P&N^KY9^"FH26'Q,TQYRW^FAX6+?Q;P<'WRP%>L?'/Q)KGA]=
M"3P_?&SDO9I(G.Q6#?<VYR#ZF@#TZBO)?^$=^,/_`$->G?\`?(_^-TW7[CQ]
MX1\`:Q?ZYKL%Q>B6`6LL"*?+4MAP05`YR/6@#URBO&=%LOBYJFDVFJV?B73S
M%=1+-&DJ+G##(!_=XS4UO\2O%/@_4H;'XDZ2HMICA+^U7CZX'#>X&#[4`>D7
M_B73[&\-K*TCNOWRBY"?U)Y'`R>:U8I8Y8UDB=71P&5@<@@]#7(7.A2:G=1Z
MGIDT%S!(1<6LOFD*"763+*`=XRO'U[8S7166DPVUG!;[G?RHU3=G&<#&<4`>
M2_%#_D=+O_<C_P#0!7+UU'Q0_P"1TN_]R/\`]`%:WPU\(+?,FKZG'FW4_P"C
MQ,.)"/XC[#MZU[<:BIT5)]CY:=&5?$RA'NQO@CP"^H!+_6D:.U.&C@Z-*/4^
M@_4UV'C36X_"^@!;)$CFD_=6R*,!..3CT`_7%=-BO-OC-;3G^S[L`F!-\;'L
MK'!'YX_2O/C-UZJ4]CUZE)83#R=+?N><2R/+(TDK,[N2S,QR6)ZDTVBBO9/F
MFPKL?A)_R-9_Z]W_`)BL70O#.K:XP^PVK>43@S2?*@_'O^%>I^#O!EKX=S<-
M(;B^==K2=%4=PH_J:Y,36A&#C?4]'`X:I*I&I;1"?%>:2#X<Z\\1(;[*RY'H
M2`?T)KF/V;X(H_`4TR`>9+>R;S]`H'Z5Z!XBTQ-:T&_TR4@+=P/#D]LC`/YU
MXS\`]>/A[7-2\':T?LT\DY,(?C]\ORLGX@`CUQ[UXQ],>[4444`<?\7]=E\/
M>`=1N[5REQ*!;Q,.JES@GZ@9-5O@OX8@\/>";.41C[9J*+<W$AZG<,JN?0`C
M\<U%\>--EU+X<7OD`L]JZ7)4=2JGYOR!)_"M?X7ZS!KG@32;F!@6C@6"4#^%
MT`4@_EGZ$4`=/5'7-)M-<TFYTW48A+;7*%'4]O0CW!Y%7JCN)H[>"2>=UCBB
M4N[L<!5`R2:`/F62\NK'X=^*O"=[(7.DW\319[`RE6`]L@'_`($:Z:\\':EX
M>T31/'/@?*7,=C#)?6BC(D78"S`=P?XA^(KD[XOK&@^./$JH5MKN^ACB)'7,
MI;]!M_.OHCP'_P`B3H?_`%X0_P#H`H&5O`'C33O&FC+>63".>/"W%L3\T+?U
M![&N._:5_P"1*LO^O]?_`$!ZI>/?"6I>"=</C;P,FV-26O[%1\I7JQ"C^$]Q
MV/(K.^+WBW3?&/PPT_4-,?#"_19X&/SPOY;_`"G^A[T"+W[0&H^1X`T*P4\W
M3HY'^RD?^+"L+XF>#I-*\`^%M<L5,=SI]M%%<,HY7=\ZM^#DC\11\87.L^,/
M">A1G=BV@4CT,K`']%%>YZYI%MK&A76DW*C[/<PF$_[/'!'TX/X4#*7@3Q!'
MXH\*6&K(1OFC`E4?PR#AA^8->3?'/4KCQ1XTTKP;I;;S$Z^8!T\U^F?]U.?Q
M-5OA'XH_X06\\1^'_$#^6MFLEPBD]9(QAE'^\-I'TJ]\`])N-=\2:KXTU4;G
M,CI$Q[R/RY'T4@?C0!E_%W2X?!GC'PI>6"[+>U@A12._DOSGZ@UT/[1L\:?\
M(K<,W[I;F20M_LCRSG\JL?M,:?Y_A?3K]1DVMT8V/H'4_P!5%<Y\3;]=8\'_
M``[NGP_G?*X/.2!&K`_B#0!Z!_PN?P-_T%G_`/`:3_"L/XH>+=&\6_"O5KC0
MKDW$=O<01R$QLF&+@]QZ5Z!_PAWAG_H7],_\!4_PKC_C3I.G:3\,-2CTRQM[
M-))H698(P@8[QR<4".J^''_(@Z!_UX0_^@"KGBO0;3Q+H-UI5^@:.="%8CF-
M_P"%A[@U3^''_(@Z!_UX0_\`H`K9U&]M]-L+B]O)!%;V\;22.>@4#)H`\Q_9
MWU.Y;1=4T&]?<^D7)1,G[JL3D?0,K?G7JU>0_L[PRW9\1Z](A2._N\1Y[X+,
MWY;P*]>H`\D\8:<=6^)OV!20)S$&([+L!)_(&O5[:&.VMXX($"1QJ$51T`'0
M5YY<W$=O\9$,I`#HL8)]3%@?K7HXKJKM\L%TL<&$BN:I+KS,*@OK.WO[62VO
M(5FAD&&1AD&IZ*Y3N:OHSBY?ACH3R%DDO(U/\"R@@?F,UI:9X'T#3F#QV*S2
M#HTY+_H>/TKHJ*U=:HU9R9A'#48NZBA$4(H50`HX``QBEHIAE02+&74.P)"D
M\D>N*R.C8?7F?Q8^%X\42#6-"=;76H@,Y.U;C'3)_A8=FKTMR54D`L0,X'>L
M7^V]0_Z%V_\`^^XO_BJ:3>Q+DH[GD>E_%GQ5X/"Z=XWT*XN#%\JSL/+D('JV
M"K_4=:OWW[05F\6S1]!N9[AAA1-(``?HN2:])FU6[GC,<_AF\E0]5=HB#^!:
MH+>Y-M)YEMX0FA?^]&L"G\PU5R,GVL?Z3.+^&4?C+Q)XFNM>\86KPZ=):/;0
MVTJ^6GS%<A8SSC`Y)ZUG7.@>*/A3KEQJ'A.UDU?P]=-NELAEFB_`<Y'9AGCJ
M*]0_MO4/^A=O_P#ON+_XJD_MO4/^A=O_`/ON+_XJCD8>UC_29PT/QZ\.>3_I
MFG:I;W(',/E*W/IG(_E6-J^M^+_BQC2M"TN;1M!D/[^[N`09%ST)[C_97.>Y
MQ7IDE_-+*)9?"ER\@Z.WDD_GNJ;^V]0_Z%V__P"^XO\`XJCD8>TC_29P7Q3\
M-VGAGX,-I&E1NT<,T1+;<M(Q?YF..YKOO`@*^"M##`@BQAR",8^04G]MZA_T
M+M__`-]Q?_%4?VWJ'_0NW_\`WW%_\51R,/:1_I,VR`P((R#P0:^?OC/\,I-'
M,^N^'(F.FRMONK6/I`W]\#^[R?\`=SZ=/9_[;U#_`*%V_P#^^XO_`(JFOK-]
M(C(_AN^96&""\1!'I]ZCD8>UC_29XOX=QXC^/D$@^>*Q"D>@$4(4?^/5]"US
ML%_-;MN@\*7,38QE/)!Q_P!]5/\`VWJ'_0NW_P#WW%_\51R,/:Q_I,\?_:'\
M)2C7[#6M.@+G4BMK(JCK,.$_,<?\!KV'P3H$7ACPO8:3$!NMXQYC#^.0\L?S
M)J"ZU&XNQ&+GPQ>2B*194W-$=KKR&'S=14W]MZA_T+M__P!]Q?\`Q5'(P]K'
M^DS(^,NG_P!H_#?6$"[GAC%POU1@Q_0&O!;G4FN/A[X64)),=,U*Y5E12Q"_
MNW'\S7T>^LWSJ5?PY?,K#!!>(@C_`+ZID&IW-NI6#PO=Q`G)"&%<_DU'(P]K
M'^DSA_\`A?&D_P#0`UC_`+]K_C6?XZ\;V_CGX8:VUAIU[:FTFMU99TY;<_8#
M/I7IG]M7_P#T+M]_WW%_\51_;>H?]"[?_P#?<7_Q5'(P]K'^DSR_PQ\8[+1_
M#.G:6/#^K7%Q:6T<!VH`K,J@<'KC\*;J/_"<_%B=+&33I/#GA[<&E,P(:0`^
M^"Q]``!GK7J7]MZA_P!"[?\`_?<7_P`52_VWJ'_0NW__`'W%_P#%4<C#VL?Z
M3+?A[1K+P_H]MI>FQ^7;6R;5!ZL>[$]R3R:T*J:;=S7<)DN+*:S8-CRY2I)'
MKP2*MU&Q:=U<\6^)KM'XWNG1BK*L1!'4':.:[+P?X_L[^".UUB5;6\4!?,;A
M)??/8^U+XH\`'7M:FU'^T?(\Q5&SRMV,#'7-9?\`PJ@_]!?_`,@?_95Z+G1J
M4XQD]4>,J>*I5I3IK1ONCT>*5)D#Q.KJ>C*<BGUYS!\,;FV_X]]?EA_W(RO\
MFJ:3X=ZC*NV7Q-=./0AC_P"S5S>SI_S_`(,[E6K6UI_BCN+F^M+0$W5U#"!U
M\R0+_.N=U3XA:!8AA#.UY(/X8%R/^^CQ7/M\*&=MSZR6/JT.3_Z%1_PJ@_\`
M08_\@?\`V5:1IT%\4K_(QG5Q;^""7S3,W6?B7JEV&CTV*.QC/\7WY/S/`_*C
MX7W,]YXQ::ZFDGE:W?+R,6/45I?\*H;_`*#'_D#_`.O6QX1\"GP[JWV[^T/M
M'[MH]GE;>N.<Y]JWE4H1IN,#EIT<5*M&=79/NCK;NXCM+6:YF)$<*-(Q'H!D
MUSVD?\))J5O:ZK)J-M:QW&R86`MMZK$<':9,YW[>XXSV-=)+&LL;1R*&1P59
M3T(/45SVGZ%K.F^196>MH-+@8;$EMM\ZQ@\1A]V",<9*YQ^=>8>X='7+VUQK
M>ORW=SIVH0Z;90326\`-N)6F9"59GR1A=P(`'.!G-=17.R:#JEE=W+Z!JL-I
M;W<IFD@N+;SA&[?>:,AAC)YP<C.3WH`N^&=3FU.QE-Y$D5Y:SO:W"QDE-ZGJ
MN><$$$9]:S/'.MSZ1+IB1:G;:7%=22+)<3Q>8HVH648R.IP/6MG0M*BT?3Q:
MQ223.SM++-(<O+(QRSGW)/X=*J^(_#MOK\MI]L8^1;^;NC`Y;>A7(/8C.0?4
M4`6?#MY<ZAH5C>7T'V>YGA5Y(\$;21Z'D?0\USWCCQ!>:3JEO;VVI6]BC6<U
MPHEMS+YTBL@6,`$'G<>G-=/I4%S:Z?!!>W7VN>)=K3E=IDQW(]<=?>H9-,W^
M((-4\W'DVTEOY>WKN96SG_@/ZT`6-.FEN=/MI[B$P32Q*[Q'JC$`E?P/%8MS
M=:KJNMWFGZ5=QZ?;6&Q9IS")9))&7<%4'@`*1DG.<X'2NBK"U'1+Y=4EU/0K
M^.SN+A%2XCGA\V*7;PK8!!#`'&0>1C(XH`?X>U"]EN[[2]6,4EY8E#YT*E5F
MC<$JVTD[3PP(SV]ZB\<:K-HVBI<P745GNNH(7N)4#+$C.%9B"1T!-6]!T<Z9
M]IGN;IKR^O'#W%PRA0V!A551]U0.@^I[T[Q!I":U:0VTKA4CN8IV#+N#A'#%
M2/0XQ0!7\':E=:KI!N+PI*5FDCCN(XS&MQ&IPL@4YP#_`/JXJWK^I+I&CW-\
MR[VB3Y(QUD<\(H]RQ`_&FZ!ICZ/8FR^TM<01N?L^\?-%%_#&3WV]`?3%1>(-
M"AUY[**^8/96\IFEMRN1,P!"9/H"<X]0/2@!OA'4[G4]&1M11(]1MW:WO$3H
MLJG!Q['AA[$57\=76I:?X?N-0TJ\2VDM5+LKPB02<@8ZC%3:+X<MM#U.[GTS
M;;VEVB;[55^42+D;P<]U(!'^R*M>(M,_MG1;K3O-\G[0FS?MSMY!Z?A0!8L(
MKB&U2.]N1=3#.Z41B/=S_=&<51;4)QXMCTW*_9VL6N",<[Q(J]?3!K6K/.F9
M\0IJOF_=M6MO+QZN&SG\,4`.UW4H]'T:[U&5#(MM$TFQ>K$=!^)XK!O9/%&E
M:7)K-U?6ES]G0SW&GI!M01@994DSNW`9P3P2.@S72:C90:C83V5VGF07$;1R
M+G&5(P:YZ3PWK%W:_P!EZCKHN-*P$<+;[;B=!_`\F[&"."0H)'IF@#IH)4G@
MCFC.4D4.I]B,BN7;Q3-8^++^QU*%4TN-X8HKP=(I'0';)Z*2>&Z9X/45U2*$
M4*H`4#``[5EQ:)#]MU::ZVW$.J;!)"Z94!4V$'US0`GA[4+B_EU5;@KBUOWM
MX]HQ\@5",^I^8UK5C^%?#\?ARTNK6"XEGBFN6G0RG<R`A0%)[XVX!],5L4`?
"_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
